Thromboembolism.
Fitzmaurice
David
D
Department of Primary Care and General Practice, The Medical School University of Birmingham, Birmingham, UK.
Hobbs
F D Richard
FD
McManus
Richard
R
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D020000:Decision Support Systems, Clinical; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy* / Q000209:etiology; D020246:Venous Thrombosis / Q000188:drug therapy* / Q000209:etiology; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014859:Warfarin; D006493:Heparin